KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Inventory (2016 - 2026)

Pfizer has reported Inventory over the past 18 years, most recently at $10.7 billion for Q1 2026.

  • Quarterly Inventory fell 1.7% to $10.7 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $10.7 billion through Mar 2026, down 1.7% year-over-year, with the annual reading at $10.7 billion for FY2025, 1.82% down from the prior year.
  • Inventory was $10.7 billion for Q1 2026 at Pfizer, roughly flat from $10.7 billion in the prior quarter.
  • Over five years, Inventory peaked at $11.7 billion in Q3 2024 and troughed at $9.0 billion in Q4 2022.
  • The 5-year median for Inventory is $10.7 billion (2025), against an average of $10.6 billion.
  • Year-over-year, Inventory rose 17.5% in 2022 and then decreased 4.39% in 2023.
  • A 5-year view of Inventory shows it stood at $9.0 billion in 2022, then grew by 13.45% to $10.2 billion in 2023, then rose by 6.5% to $10.9 billion in 2024, then dropped by 1.82% to $10.7 billion in 2025, then increased by 0.12% to $10.7 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Inventory are $10.7 billion (Q1 2026), $10.7 billion (Q4 2025), and $11.5 billion (Q3 2025).